Press Releases

Nordion Announces Europe-Focused Phase III Clinical Trial for TheraSphere Liver Cancer Treatment (Apr. 24, 2012)

Nordion Launches Custom Doses for TheraSphere® Liver Cancer Therapy in Europe and Canada (Mar. 25, 2012)

TheraSphere® Providing Hope to Liver Cancer Patients in Turkey
(Turkish/Türkçe) (Feb. 17, 2012)

Nordion Awards Contract for Phase III Clinical Trials to Theorem Clinical Research (Jun. 16, 2011)

Nordion Reports TheraSphere^® Phase II Clinical Trial Results at Society of Interventional Radiology (Mar. 28, 2011)

Nordion announces Phase III clinical trial to evaluate TheraSphere^® in treatment of unresectable hepatocellular carcinoma (Mar. 23, 2011)

Nordion announces Phase III clinical trial to evaluate TheraSphere^® for liver metastases in colorectal cancer patients (Mar. 23, 2011)

TheraSphere® Highlighted at the Society of Interventional Radiology's 35th Annual Scientific Meeting (Mar. 16, 2010)

Therasphere for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers(Feb. 5, 2010)

Nordion Launches Improved TheraSphere® Administration System for Physicians (Mar. 9, 2008)

Procedure Offers time, hope for liver cancer patients (Jan. 3, 2008)

Nordion Establishes European Centers of Excellence for Innovative Liver Cancer Therapy (Feb. 8, 2007)

First Patients in India Receive Innovative Treatment for Primary Liver Cancer (Jan. 17, 2007)

Expanded use for TheraSphere® offers physicians an innovative alternative to traditional liver cancer therapies (Jan. 10, 2007)